Adenosine A2A receptors enhance GABA transport into nerve terminals by restraining PKC inhibition of GAT-1

Journal of Neurochemistry

Volumn 109, Issue 2, 2009, Pages 336-347

  Cristóvão Ferreira, Sofia ^a   Vaz, Sandra H ^a   Ribeiro, Joaquim A ^a   Sebastião, Ana M ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

A2A receptors; Adenosine; GABA transport; GABA transporter 1; Protein kinase A; Protein kinase C

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID CARRIER; 4 BETA PHORBOL DIDECANOATE; [2 (2 FURANYL) 7 (2 PHENYLETHYL) 7H PYRAZOLO(4,3E)(1,2,4)TRIAZOLO(1,5C)PYRIMIDIN 5 AMINE; [2 [2 (3 DIMETHYLANIMOPROPYL)INDOL 3 YL] 3 (INDOL 3 YL)MALEIMIDE; [4 [2 [6 AMINO 9 (N ETHYL BETA DEXTRO RIBOFURANURONAMIDOSYL) 9H PURIN YL]AMINO]ETHYL]BENZENEPROPANOIC ACID HYDROCHLORIDE; [N [2 (P BROMOCINNAMYLAMINO) ETHYL] 5 ISOQUINOLINESULFONAMIDE DIHYDROCHLORIDE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE A2B RECEPTOR; ADENOSINE DEAMINASE; ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; FORSKOLIN; GABA TRANSPORTER 1; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; MALE; NERVE ENDING; NEUROTRANSMISSION; NEUROTRANSMITTER UPTAKE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

ANIMALS; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GAMMA-AMINOBUTYRIC ACID; INDOLES; MALE; MALEIMIDES; PRESYNAPTIC TERMINALS; PROTEIN KINASE C; PROTEIN TRANSPORT; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A2A;

HUMAN ECHOVIRUS 1;

EID: 62649146409     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.05963.x     Document Type: Article

References (32)

1. Awad J. A., Johnson R. A., Jakobs K. H. Schultz G. (1983) Interactions of forskolin and adenylate cyclase. Effects on substrate kinetics and protection against inactivation by heat and N-ethylmaleimide. J. Biol. Chem. 258 (5 2960 2965.
2. Bahena-Trujillo R. Arias-Montaño J. A. (1999) [3H] gamma-aminobutyric acid transport in rat substantia nigra pars reticula synaptosomes: pharmacological characterization and phorbol ester-induced inhibition. Neurosci. Lett. 274 (2 119 122.
3. Borden L. A. (1996) GABA transporter heterogeneity: pharmacology and cellular localization. Neurochem. Int. 29 (4 335 336.
4. Bradford M. M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248 254.
5. Bruns R. F., Fergus J. H., Badger E. W., Bristol J. A., Santay L. A., Hartman J. D., Hays S. J. Huang C. C. (1987) Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn Schmiedebergs Arch. Pharmacol. 335 (1 59 63.
6. Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkawa U. Nishizuka Y. (1982) Direct activation of calcium-activated, phospholipiddependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 257 (13 7847 7851.
7. Chijiwa T., Mishima A., Hagiwara M., Sano M., Hayashi K., Inoue T., Naito K., Toshioka T. Hidaka H. (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5- isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265 (9 5267 5272.
8. Conti F., Minelli A. Melone M. (2004) GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications. Brain Res. Rev. 45 (3 196 212.
9. 3H]GABA release from hippocampal nerve terminals. Neuropharmacology 39 (7 1156 1167.
10. Cunha-Reis D., Ribeiro J. A. Sebastião A. M. (2008) A1 and A2A receptor activation by endogenous adenosine is required for VIP enhancement of K(+)-evoked [(3)H]-GABA release from rat hippocampal nerve terminals. Neurosci. Lett. 430 (3 207 212.
11. Fresco P., Diniz C. Gonçalves J. (2004) Facilitation of noradrenaline release by activation of adenosine A2A receptors triggers both phospholipase C and adenylate cyclase pathways in the rat tail artery. Cardiovascular Res. 63 (4 739 746.
12. Gether U., Andersen P. H., Larsson O. M. Schousboe A. (2006) Neurotransmitter transporters: molecular function of important drug targets. Trends Pharmacol. Sci. 27 (7 375 383.
13. Gonzalez B., Paz F., Florán L., Aceves J., Erlij D. Florán B. (2006) Adenosine A2A receptor stimulation decreases GAT-1-mediated GABA uptake in the globus pallidus of the rat. Neuropharmacology 51 (1 154 159.
14. Guastella J., Nelson N., Nelson H., Czyzyk L., Keynan S., Miedel M. C., Davidson N., Lester H. A. Kanner B. I. (1990) Cloning and expression of a rat brain GABA transporter. Science 249 (4794 1303 1306.
15. Gubitz A. K., Widdowson L., Kurokawa M., Kirkpatrick K. A. Richardson P. J. (1996) Dual signalling by the adenosine A2A receptor involvesactivation of both N- and P-type calcium channels by different G proteins and protein kinases in the same striatal nerve terminals. J. Neurochem. 67 (1 374 381.
16. Iversen L. L. Kelly J. S. (1975) Uptake and metabolism of gamma-aminobutyric acid by neurons and glial cells. Biochem. Pharmacol. 24 (9 933 938.
17. Jarvis M. F., Schulz R., Hutchison A. J., Do U. H., Sills M. A. Williams M. (1989) [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J. Pharmacol. Exp. Ther. 251 (3 888 893.
18. Kim Y. C., Ji X., Melman N., Linden J. Jacobson K. A. (2000) Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors. J. Med. Chem. 43 (6 1165 1172.
19. Kirk I. P. Richardson P. J. (1995) Inhibition of striatal GABA release by the adenosine A2A receptor is not mediated by increases in cyclic AMP. J. Neurochem. 64 (6 2801 2809.
20. Linden J. (2001) Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41, 775 787.
21. Millán C., Torres M. Sánchez-Prieto J. (2003) Co-activation of PKA and PKC in cerebrocortical nerve terminals synergistically facilitates glutamate release. J. Neurochem. 87 (5 1101 1111.
22. Mundell S. J., Benovic J. L. Kelly E. (1997) A dominant negative mutant of the G protein-coupled Kinase 2 selectively attenuates adenosine A2 Receptor desensitization. Mol. Pharmacol. 51 (6 991 998.
23. Peakman M. C. Hill S. J. (1994) Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes. Br. J. Pharmacol. 111 (1 191 198.
24. Ribeiro J. A., Sebastião A. M. de Mendonça A. (2003) Adenosine receptors in the nervous system: pathophysiological implications. Prog. Neurobiol. 68 (6 377 392.
25. Sebastião A. M. Ribeiro J. A. (2000) Fine-tuning neuromodulation by adenosine. Trens Pharmacol. Sci. 21 (9 341 346.
26. Sugita S., Douglas A. B. Byrne J. H. (1997) Modulation of cAMP/protein kinase A cascade by protrein kinase C in sensory neurons of aplysia. J. Neurosci. 17 (19 7237 7244.
27. Toullec D., Pianetti P., Coste H. et al. (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266 (24 15771 15781.
28. Vaz S. H., Cristóvão-Ferreira S., Ribeiro J. A. Sebastião A. M. (2008) Brain-derived neurotrophic factor inhibits GABA uptake by the rat hippocampal nerve terminals. Brain Res. 1219, 19 25.
29. Wang D. Quick M. W. (2005) Trafficking of the plasma membrane gamma-aminobutyric acid transporter GAT1. Size and rates of an acutely recycling pool. J. Biol. Chem. 280 (19 18703 18709.
30. Williams M., Braunswalder A. Erickson T. J. (1986) Evaluation of the binding of the A1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue. Naunyn-Schmiedeberg's Arch. Pharmacol. 332 (2 179 183.
31. Wood J. D. Sidhu H. S. (1986) Uptake of gamma-aminobutyric acid by brain tissue preparations: a reevaluation. J. Neurochem. 46 (3 739 744.
32. Zocchi C., Ongini E., Conti A., Monopoli A., Negretti A., Baraldi P. G. Dionisotti S. (1996) The non-xanthine heterocyclic compound SCH58261 is a new potent and selective A2A adenosine receptor antagonist. J. Pharmacol. Exp. Ther. 276 (2 398 404.